StructuralGenomicsConsortium/CNP43_SARS-CoV-2_nsP13-Helicase_pyrrolidine

AI Summary: The task involves separating the enantiomers of a SARS-CoV-2 nsP13 helicase inhibitor (RA-0205665) on a gram scale. This requires expertise in classical resolution or other enantiomer separation techniques. The goal is to obtain sufficient quantities of each enantiomer for further biological testing and analog preparation, ultimately aiding in drug design and development.